Diabetes, Vol 48, Issue 4 834-838, Copyright © 1999 by American Diabetes Association

ARTICLES

Effect of insulin on fat metabolism during and after normal pregnancy

E Sivan, CJ Homko, X Chen, EA Reece and G Boden
Department of Obstetrics and Gynecology, Temple University Hospital, Philadelphia, Pennsylvania 19140, USA.

Whereas development of resistance to the action of insulin on glucose metabolism during gestation has been recognized, it is presently not known whether there is also resistance to the action of insulin on lipid metabolism. We have, therefore, examined the effect of physiological hyperinsulinemia (during euglycemic-hyperinsulinemic clamping) on free fatty acid (FFA) turnover in seven nondiabetic overweight or obese women during and after pregnancy. Basal rates of FFA release, oxidation, and reesterification and basal plasma FFA concentrations were not significantly different from each other during the 2nd and 3rd trimester of pregnancy and postpartum. During euglycemic-hyperinsulinemic (approximately 500 pmol/l) clamping, however, lipolysis was significantly less inhibited during the 3rd trimester (from 7.0 +/- 0.9 to 4.9 +/- 0.9 micromol x kg(-1) x min(-1), -30%) than during the 2nd trimester (from 8.4 +/- 0.6 to 4.1 +/- 0.9 micromol x kg(-1) x min(-1), -51%) and postpartum (from 8.5 +/- 1.1 to 4.2 +/- 0.6 micromol x kg(-1) x min(-1), -51%). Similarly, fat oxidation was not inhibited at all (from 3.5 +/- 0.3 to 3.8 +/- 0.5 micromol x kg(-1) x min(-1)) during the 3rd trimester but was suppressed by 51% (from 3.9 +/- 0.2 to 1.9 +/- 0.3 micromol x kg(-1) x min(-1)) during the 2nd trimester and by 38% (from 2.6 +/- 0.7 to 1.6 +/- 0.5 micromol x kg(-1) x min(-1) postpartum. These data demonstrated that resistance to the action of insulin on lipolysis and on fat oxidation developed during late gestation and disappeared postpartum.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. L. Magnusson-Olsson, S. Lager, B. Jacobsson, T. Jansson, and T. L. Powell Effect of maternal triglycerides and free fatty acids on placental LPL in cultured primary trophoblast cells and in a case of maternal LPL deficiency Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E24 - E30. [Abstract] [Full Text] [PDF]

				M. Hod and Y. Yogev Goals of Metabolic Management of Gestational Diabetes: Is it all about the sugar? Diabetes Care, July 1, 2007; 30(Supplement_2): S180 - S187. [Full Text] [PDF]

				K S. Nair Aging muscle Am. J. Clinical Nutrition, May 1, 2005; 81(5): 953 - 963. [Abstract] [Full Text] [PDF]

				P. M. Catalano, J. P. Kirwan, S. Haugel-de Mouzon, and J. King Gestational Diabetes and Insulin Resistance: Role in Short- and Long-Term Implications for Mother and Fetus J. Nutr., May 1, 2003; 133(5): 1674S - 1683. [Abstract] [Full Text] [PDF]

				T. O. Scholl, M. Sowers, X. Chen, and C. Lenders Maternal Glucose Concentration Influences Fetal Growth, Gestation, and Pregnancy Complications Am. J. Epidemiol., September 15, 2001; 154(6): 514 - 520. [Abstract] [Full Text] [PDF]

				P. M. Catalano, S. E. Nizielski, J. Shao, L. Preston, L. Qiao, and J. E. Friedman Downregulated IRS-1 and PPARgamma in obese women with gestational diabetes: relationship to FFA during pregnancy Am J Physiol Endocrinol Metab, March 1, 2002; 282(3): E522 - E533. [Abstract] [Full Text] [PDF]